Table 2.
Variable | Total | Deaths | Live Discharges | p-Value |
---|---|---|---|---|
(N = 75) | (N = 55) | (N = 20) | ||
Median age, years (IQR) | 64 (54–71) | 69 (62–72.5) | 47 (38.5–56) | < 0.001 (w) |
Sex, n (%) | 0.127 (f) | |||
Male | 57 (76) | 39 (70.9) | 18 (90) | |
Female | 18 (24) | 16 (29.1) | 2 (10) | |
Current smokers, n (%) | 10 (13.3) | 7 (12.7) | 3 (15) | 1.000 (f) |
Comorbidities (at least one), n (%) | 67 (89.3) | 52 (94.6) | 15 (75) | 0.045 |
Arterial hypertension | 39 (52.0) | 32 (58.2) | 7 (35) | 0.130 |
Obesity | 23 (30.7) | 18 (32.7) | 5 (25) | 0.719 |
Diabetes mellitus | 21 (28.0) | 17 (30.9) | 4 (20) | 0.401 (f) |
Chronic obstructive pulmonary disease | 13 (17.3) | 12 (21.8) | 1 (5) | 0.165 (f) |
Chronic heart disease | 11 (14.7) | 10 (18.2) | 1 (5) | 0.269 (f) |
Solid malignant disease | 9 (12.0) | 6 (10.9) | 3 (15) | 0.693 (f) |
Rheumatological disease | 7 (9.3) | 5 (9.1) | 2 (10) | 1.000 (f) |
Chronic kidney disease | 5 (6.7) | 5 (9.1) | 0 (0) | 0.316 (f) |
Asthma | 4 (5.3) | 3 (5.5) | 1 (5) | 1.000 (f) |
Other chronic lung diseases | 4 (5.3) | 4 (7.3) | 0 (0) | 0.568 (f) |
Liver disease | 3 (4.0) | 2 (3.6) | 1 (5) | 1.000 (f) |
Hematological malignant disease | 3 (4.0) | 3 (5.5) | 0 (0.0) | 0.560 (f) |
HIV infection | 1 (1.3) | 1 (1.8) | 0 (0) | 1.000 (f) |
Respiratory status, n (%) | ||||
SatO2 < 90% on admission | 11 (17) | 9 (16.3) | 2 (10) | 0.717 (f) |
Abbreviations: (f), Fisher’s Exact Test; HIV, human immunodeficiency virus; IQR, interquartile range; SatO2, oxygen saturation; (w), Wilcoxon Rank Sum Test.